SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy Volunteers
5 references·6 citing·40 second hop
Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy Volunteers (2001)Vigabatrin Decreases Cholecystokinin-Tetr…Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. (1997)Effects of citalopram treatme…Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders (1996)Reliability and procedural va…Flumazenil Provocation of Panic Attacks (1990)Flumazenil Provocation of Pan…Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic Disorder (1990)Cholecystokinin-Tetrapeptide …Measurement of lactate-induced panic and anxiety (1987)Measurement of lactate-induce…Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview (2020)Peripheral Biomarkers in DSM-…Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study (2007)Evaluation of the CCK-4 model…Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder (2005)Selective GABAergic treatment…Antiepileptic Drugs in the Treatment of Anxiety Disorders (2004)Antiepileptic Drugs in the Tr…Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers (2003)Effects of tiagabine on chole…Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study (2002)Effects of Alprazolam on Chol…A personality scale of manifest anxiety. (1953)The development of an affect adjective check list for the measurement of anxiety. (1960)Lactate Metabolism in Anxiety Neurosis (1967)Responses of “generalized” and “discrete” social phobics during public speaking (1993)Sympathetic Activity in Patients With Panic Disorder at Rest, Under Laboratory Mental Stress, and During Panic Attacks (1998)A critical review of the empirical literature on the relation between anxiety and puberty (2008)Investigation of cholecystokinin system genes in panic disorder (1999)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)The development of a Clinician-Administered PTSD Scale (1995)Anxiety and medical disorders (2005)Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: Randomized, double-blind placebo-controlled study (2007)Diagnostic and Statistical Manual of Mental Disorders (2013)Genetic Factors in Anxiety Disorders (1983)A cognitive approach to panic (1986)Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial (1988)Neurobiology of panic disorder (1998)SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder (2000)Is obsessive–compulsive disorder an anxiety disorder? (2006)A Coefficient of Agreement for Nominal Scales (1960)National Institute of Mental Health Diagnostic Interview Schedule (1981)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Improving accuracy of major depression age‐of‐onset reports in the US National Comorbidity Survey (1999)Cost-effectiveness and Cost Offset of a Collaborative Care Intervention for Primary Care Patients With Panic Disorder (2002)Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community (2003)Diagnostic and Statistical Manual of Mental Disorders, 3rd ed (1981)Evidence-based pharmacotherapy of panic disorder (2005)The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders (2008)Evidence-based pharmacotherapy of panic disorder: an update (2011)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)A New Depression Scale Designed to be Sensitive to Change (1979)Panic Disorder-A Malfunction of Multiple Transmitter Control Systems within the Midbrain Periaqueductal Gray Matter? (2000)Functional neuroanatomy of CCK‐4‐induced panic attacks in healthy volunteers (2007)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Global prevalence of anxiety disorders: a systematic review and meta-regression (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline (2024)A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety (2008)Cholecystokinin and anxiety (1990)Neuroimaging in anxiety disorders (2011)
this work references cited by second hop

References

  • 1990Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic Disorder293 cited
  • 1990Flumazenil Provocation of Panic Attacks272 cited
  • 1987Measurement of lactate-induced panic and anxiety221 cited
  • 1996Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders153 cited
  • 1997Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.116 cited

Cited by

  • 2005Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder87 cited
  • 2002Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study81 cited
  • 2004Antiepileptic Drugs in the Treatment of Anxiety Disorders78 cited
  • 2020Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview47 cited
  • 2007Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study45 cited
  • 2003Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers45 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work